Redmond Asset Management, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 23 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Redmond Asset Management, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$883,963
-56.9%
137,689
-50.0%
0.29%
-19.2%
Q1 2023$2,051,566
+241.0%
275,378
+100.0%
0.36%
+64.4%
Q4 2022$601,701
-22.3%
137,6890.0%0.22%
-25.0%
Q3 2022$774,000
-2.8%
137,689
-0.2%
0.29%
+0.7%
Q2 2022$796,000
-43.1%
137,9420.0%0.29%
-31.4%
Q1 2022$1,399,000
+23.3%
137,942
+0.6%
0.42%
+31.5%
Q4 2021$1,135,000
+2.6%
137,098
+0.4%
0.32%
-8.4%
Q3 2021$1,106,000
+57.5%
136,593
+3.7%
0.35%
+68.0%
Q2 2021$702,000
+38.2%
131,7310.0%0.21%
+30.4%
Q1 2021$508,000131,7310.16%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders